DAPACROSS-10MG TAB
— Product

DAPACROSS-10MG TAB

DAPAGLIFLOZIN 10MG

DAPACROSS-10MG TAB is a tablet of dapagliflozin 10 mg, an SGLT2 inhibitor. It is used in type 2 diabetes mellitus to improve glycaemic control at the standard maintenance strength, and in appropriate patients for its established cardiovascular and renal protective effects.

01

Benefits

  • Lowers blood glucose by blocking renal glucose reabsorption, independent of insulin secretion or sensitivity.
  • The 10 mg dose is the strength at which the cardiovascular and renal outcome benefits of dapagliflozin were established.
  • Reduces hospitalisation for heart failure and slows the progression of chronic kidney disease in suitable patients.
  • Produces modest weight loss and a modest fall in blood pressure.
  • Low risk of hypoglycaemia when used alone, as the action is glucose-dependent.
  • Once-daily dosing, taken with or without food.
02

Side effects

Not everyone gets these. Most are mild and settle as the course finishes.

Common
  • Genital fungal infection — thrush in women, balanitis in men
  • Urinary tract infection
  • Increased urine output and thirst
  • Dizziness on standing
Less common
  • Dehydration and a fall in blood pressure
  • Rise in serum creatinine on starting, usually settling
  • Constipation or nausea
  • Back pain
Stop and get medical help if any of these occur
  • Nausea, vomiting, abdominal pain, deep rapid breathing or confusion — this may be ketoacidosis even with a near-normal blood glucose
  • Severe pain, redness, swelling or blackening of the skin between the genitals and anus, with fever
  • Fever with loin pain, or blood in the urine
  • Marked dizziness, fainting or a very reduced urine output
  • Signs of severe dehydration
03

Precautions

  • Can cause euglycaemic diabetic ketoacidosis — ketoacidosis with a normal or only mildly raised glucose. Patients must know the symptoms and that a normal reading does not exclude it.
  • Stop before major surgery, during acute serious illness, and during prolonged fasting or a very low carbohydrate diet.
  • Contraindicated in type 1 diabetes and in a history of diabetic ketoacidosis.
  • Genital fungal infection is common; counsel on hygiene and fluid intake before starting.
  • Fournier's gangrene has been reported — perineal pain, redness or swelling with fever needs emergency assessment.
  • Check renal function before starting and periodically; glucose-lowering efficacy falls as renal function declines.
  • Use with caution alongside diuretics, insulin and sulphonylureas, where dose reduction of the latter two may be needed.
  • Contraindicated in pregnancy and breastfeeding.